Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
December 20 Product: Vertex Pharmaceuticals Alyftrek Indication: Adults and children aged 6 and up with cystic fibrosis and at least one F508del mutation or another mutation in the CFTR gene that is responsive to the treatment Vertex Pharmaceuticals said Friday the FDA has approved its next cystic fibrosis product Alyftrek, clearing the biotech to market a product designed to improve on Trikafta
Gastric acid protection through enteric coating may improve absorption but increases formulation costs
Alcohol and many weight-loss drugs act on the central nervous system, causing various effects that can be unpredictable and potentially harmful
Selected Data 1) The study conducted by researchers Tukhovskaya et al aimed to investigate the neuroprotective and motor function recovery effects of intranasal Delta Sleep-Inducing Peptide (DSIP) in Sprague-Dawley (SD) rats subjected to focal stroke induced by middle cerebral artery occlusion (MCAO)
The micro-channels created allow topical GHK-CU to reach deeper dermal layers where it can stimulate collagen production more effectively
US$ 25.47
US$ 25.30
US$ 22.38
US$ 26.60
